Research News

Graham Bull Prize and Goulstonian Lecture 2016

Wednesday, 16 September 2015 13:51

The Graham Bull prize was established in 1988 in honour of Sir Graham Bull, who was the first director of the Clinical Research Centre at Northwick Park. A trust for the Graham Bull Prize was set up to provide money for young research workers under the age of 45 who feel that they have made a major contribution to clinical science. The prize as designed by the trust is specifically for an application and not for nomination of individuals. The work can cover a wide range of expertise, such as molecular and cellular biology, imaging technology, psychiatry, or health sciences. The award is open to RCP members and fellows who must apply for their own work to be considered. The sum of £1,000 is offered on a competitive basis each year.

The winner of this prize will also be invited to deliver the Goulstonian Lecture, an annual lecture endowed in 1635 by Mrs Ellen Goulston in memory of her husband, Dr Theodore Goulston FRCP.


Researchers must be under the age of 45 years on 1 April 2016, and must be a member or fellow of RCP London.

How to apply

The 2016 round closes on 1 April 2016. For more information on this award please email the Funding and Awards administrator: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Biomedical Catalyst (Round 8) winners announced

Friday, 21 August 2015 14:37

The MRC has announced that 12 new treatments, diagnostics and medical technologies will receive funding from the eighth round of the successful Biomedical Catalyst (BMC) programme jointly run by Innovate UK and the MRC, which contributed £13m of the total £18m in this round.

Two of the 7 MRC-funded projects are in gastroenterology.

Targeted therapy for inflammatory bowel disease


Crohn's disease is a chronic, inflammatory bowel disease, which can cause severe symptoms including abdominal pain, diarrhoea and weight loss, but for which there is currently no cure. Existing therapies are focused on reducing inflammation of the bowel lining and providing temporary relief of symptoms, but researchers at KCL and the NIHR Comprehensive Biomedical Research Centre are searching for a cure. The team are the first in the world to trial a personalised treatment using T cell therapy in patients with the disease with the hope that, if successful, their research could help other debilitating autoimmune disorders.

Spotting bowel cancer sooner with a fluorescent dye


Spraying a fluorescent dye onto the lining of the bowel could help doctors distinguish between normal and cancerous tissue in the bowel. Normal endoscopy to look for bowel cancer can only spot visible, physical changes to the lining of the bowel. Researchers at the University of Oxford will trial the new approach in 50 patients which will coat the bowel in the dye - it will only stick to healthy tissue leaving a 'black spot' where cancerous cells are. They hope that the technique will help spot cancers earlier, when it's more likely that they can be treated successfully.

Early Diagnosis Innovation Workshop

Friday, 21 August 2015 13:35

The first early diagnosis innovation workshop, on 14-16th December in Oxfordshire.

Theme: "Harnessing technology to detect cancer earlier"

Director: Dr Andrew Roddam

Deadline: 21st September

Early Diagnosis Training Workshop For Early Career Researchers

Friday, 21 August 2015 13:34

An early diagnosis training workshop for early career researchers on 7th October 2015 in London.

Aim: Improving quality of funding applications

Facilitators: Dr Peter Murchie, Dr Fiona Walter and Dr Katriina Whitaker and Dave Manton (CRUK patient involvement coach)

Deadline: 4th September

To apply, fill out the application form and send to Anna Lawrence-Jones by 5pm on 4 September 2015.

Page 4 of 7